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Objectives: The aim of this study was to investigate the effect of manuka honey, artificial honey and an
antibacterial component (methylglyoxal) on cell division in methicillin-resistant Staphylococcus aureus (MRSA).
Methods: Viability of epidemic MRSA-15 NCTC 13142 incubated with manuka honey, artificial honey and
methylglyoxal was determined, and structural effects monitored by electron microscopy. Activity of murein
hydrolase (a peptidoglycan-degrading enzyme implicated in cell separation, encoded by atl) was estimated
by cell wall hydrolysis and zymography; expression of atl was quantified by real-time PCR.
Results: Growth of MRSA was inhibited by 5%, 10% and 20% (w/v) manuka honey and 10% (w/v) artificial
honey containing methylglyoxal, but not 10% (w/v) artificial honey. Statistically significantly increased
numbers of cells containing septa and increased cell diameter (P,0.001 and P,0.001, respectively) were
found in MRSA exposed to 5%, 10% or 20% (w/v) manuka honey, but not 10% (w/v) artificial honey with
and without methylglyoxal. Intracellular activity of murein hydrolase was elevated in MRSA grown in 10%
(w/v) artificial honey and at undetectable levels in MRSA treated with 10% (w/v) manuka honey. Increased
atl expression was found in MRSA treated with 10% (w/v) manuka honey and 10% artificial honey containing
methylglyoxal.
Conclusions: Enlarged cells containing septa were observed in MRSA exposed to inhibitory concentrations of
manuka honey, suggesting that cell division was interrupted. These changes were not caused by either the
sugars or methylglyoxal in honey and indicate the presence of additional antibacterial components in
manuka honey.
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Introduction
Staphylococcus aureus is a major cause of wound infection
throughout the world and the prevalence of multidrug-resistant
strains demands innovative interventions. Honey is an ancient
wound remedy that has been reintroduced into modern medi-
cine for the topical treatment of wounds, and licensed products
containing medical-grade honey are available in Australasia,
Europe and North America.
Honey has a complex chemistry, and its broad-spectrum anti-
microbial activity varies with floral source, climate and harvest-
ing conditions. Although the precise mode of action of honey is
unknown, components that contribute to its antimicrobial
activity include a high sugar content, low water content, low
pH and the formation of hydrogen peroxide on dilution.1 Antibac-
terial phenolic components have been identified in honey2 and
an antimicrobial peptide has been discovered in a Dutch
medical-grade honey that was produced from an undisclosed
floral source cultivated in glasshouses.3 Methylglyoxal (MGO)
was identified as the dominant active antibacterial component
of manuka honey (MH),4,5 but its effect on bacterial structure
and function is unknown.
MH is derived from nectar that has been collected by honey
bees (Apis mellifera) foraging on a shrub known as manuka
(Leptospermum scoparium) that is indigenous to New Zealand.
It is used in modern wound-care formulations and has been
shown to eradicate methicillin-resistant S. aureus (MRSA) from
wounds.6 – 9 In vitro clinical isolates of methicillin-susceptible
and methicillin-resistant staphylococci were shown to be
equally susceptible to MH with MICs reported as ,3% (v/v)
[equivalent to 41000 mg/L or 4.1% (w/v)].10,11 Exposure of
S. aureus to 10% (w/v) MH for 4 h was found to interrupt the
cell cycle during cytokinesis when cells containing septa accu-
mulated.12 Cell division in staphylococci is normally preceded
by the formation of a septum at the cell equator, closely fol-
lowed by cleavage to achieve the separation of the two daughter
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cells. Accumulation of cells containing septa would result if
either defective septa had formed or if septum cleavage was
deficient. Murein hydrolases, otherwise known as autolysins,
are a diverse family of enzymes that hydrolyse structural com-
ponents in the cell wall, such as peptidoglycan. A deficiency in
murein hydrolases has been reported to lead to the failure of
cells to separate.13 – 16 These enzymes are encoded by the atl
gene17 and increased sensitivity to MH in S. aureus atl mutants
has implicated this target site in failure to complete cell
division.12
The aim of this study was to investigate the effect of MH on
the cell cycle of MRSA. It was important to establish the kinetics
of inhibition in vitro in order to determine the contributions made
by sugars and MGO, and to select appropriate times and honey
concentrations for structural studies. To investigate whether
interrupted cell division was due to defective cell separation,
the effect of MH on the activity of murein hydrolases was deter-
mined by enzyme assay and zymography, and the expression of
atl was determined by real-time PCR.
Materials and methods
General
Throughout this study, epidemic MRSA-15 (EMRSA-15) NCTC 13142 was
utilized.
A non-sterile MH (M109) was provided by Professor Molan of the
University of Waikato, New Zealand for the structural studies, and
sterile MH (Activonw) was provided by Advancis Medical (Nottingham,
UK) for other experiments. Both MH samples had antibacterial activity
equivalent to 18% (w/v) phenol, which was determined against
S. aureus NCTC 6571 by an agar well diffusion assay.18 In order to
demonstrate whether any observed effects were due to sugar content,
100 g of an artificial honey (AH) was prepared by dissolving 1.5 g of
sucrose in 17 mL of sterile deionized water and adding 7.5 g of
maltose, 40.5 g of fructose and 33.5 g of D-(+)-glucose with vigorous
mixing and gentle warming to dissolve.11,19
Cultivation conditions
EMRSA-15 NCTC 13142 was grown in nutrient broth (NB) (Oxoid,
Cambridge, UK) containing a range of concentrations of MH [0%, 2.5%,
5%, 10% and 20% (w/v)] and in NB with either 10% (w/v) AH or 10%
(w/v) AH containing 614 mg/kg MGO. The concentration of MGO
employed was appropriate for a 10% (w/v) solution of the samples of
MH used here.4,5 All cultures were incubated at 378C with shaking at
120 cycles per min, and samples were removed at known time intervals
for time–kill analyses, electron microscopy, murein hydrolase assays and
zymography.
Time–kill studies
The viability of MRSA, cultivated as described above, was determined at
time 0, 30, 60, 90, 120, 240 and 1440 min by serial decimal dilution in
one-quarter strength Ringer’s solution and Miles Misra surface drop
counts using tryptone soya agar plates (Oxoid) incubated at 378C for
24 h.
Transmission electron microscopy (TEM)
Samples (4.5 mL) of MRSA broth cultures prepared as described above
were collected at time 0, 30, 60, 90, 120, 240 and 1440 min, and
centrifuged for 1 min at 12000 g in a microfuge (MSE Micro Centaur,
Sanyo). Each pellet was resuspended in 750 mL of 3% phosphate-
buffered glutaraldehyde for 1 h at room temperature, reharvested and
washed twice in PBS before fixing in 1% phosphate-buffered osmium
tetroxide.20 After dehydration in a graded series of ethanol alcohol and
two changes in propylene oxide, cells were embedded in Araldite resin.
Ultrathin sections were stained with uranyl acetate followed by lead
citrate and examined in a 1210 JEOL transmission electron micro-
scope.20,21 Up to 12 micrographs for each timepoint and each honey con-
centration were prepared at ×20000 magnification, and cells were
observed for evidence of septal components and percentages calculated.
Images were also collected at ×32000 magnification in order to assess
fine structural changes. Using ImageJ software (NIH), cell diameters
were measured using an average of 677 cells for each timepoint and
each honey concentration.
Preparation of extracts for enzyme studies
EMRSA-15 NCTC 13142 was cultivated in NB with and without sterile 10%
(w/v) MH and in NB containing 10% (w/v) AH at 378C with shaking at 120
cycles per min. Samples (200 mL) were collected at time 0, 60, 120, 240,
720, 1080 and 1440 min, and harvested by centrifugation (Sorvall RC-5B;
Du Pont Instruments) for 20 min at 6500 g and 48C. Supernatants and
cell pellets were collected. To investigate the activity of extracellular
murein hydrolase, supernatants were concentrated 100-fold by using
Centricon PL-10 concentrators (Millipore, Bedford, UK) and centrifuging
(Sorvall RC-5B; Du Pont Instruments) for 115 min at 3000 g and 48C;
pellets were stored at 2208C until assayed. To investigate the activity
of intracellular murein hydrolase, each cell pellet was resuspended in
20 mL of sterile PBS (Oxoid) and a cell-free extract was prepared by
passage through a French press (American Instruments) at 3000
pounds per square inch. The resulting suspension was centrifuged
(Sorvall RC-5B; Du Pont Instruments) for 30 min at 4500 g and 48C to
remove whole cells or large agglutinated proteins. The resultant super-
natant (intracellular extract) was collected and stored at 2208C. The
protein concentration of all extracts was estimated using the Bradford
method (Bio-Rad, Hemel Hempstead, UK).22 – 24
Murein hydrolase enzyme assays
Murein hydrolase activity was estimated by a cell wall hydrolysis assay.25
Briefly, 200 mg of protein from either intracellular (cell-free extract) or
extracellular extracts (supernatant) was added to a cell wall suspension
containing 1.0 mg/mL autoclaved and lyophilized Micrococcus
lysodeiktikus cells (Sigma, Gillingham, Dorset, UK) in 100 mM Tris-HCl
(pH 8.0) and incubated at 378C with shaking (250 cycles per min). The
optical density at 580 nm was monitored at 30 min intervals using a
spectrophotometer (Cecil, Cambridge, UK) and the hydrolysis of cell
walls was demonstrated by decreasing optical density.
Murein hydrolase profiles by zymography
Extracellular and intracellular extracts (containing 15 mg of protein) were
electrophoresed in SDS–polyacrylamide gel (15%) containing 1% (w/v)
M. lysodeiktikus cells (Sigma) using a Criterion cassette (Bio-Rad). Color-
burstTM size markers were included (Bio-Rad). Following electrophoresis,
gels were incubated in renaturation buffer (25 mM Tris-HCl, pH 8.0) con-
taining Triton X-100 overnight at 378C, stained with 0.01% (w/v) methyl-
ene blue in 0.1% (w/v) KOH and destained with deionized water.26 Gels
were photographed using an AutoChemi system (Ultra-Violet Products
Ltd, Cambridge, UK) and murein hydrolase activity was detected as
unstained bands in the gel.
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Extraction of RNA and real-time PCR
To determine the effect of MH and MGO on the expression of the atl gene
that encodes murein hydrolases, MRSA was grown in NB with and without
10% (w/v) MH and in NB with 10% (w/v) AH containing MGO at 378C for
4 h. RNA was isolated using the Promega SV Total RNA Isolation Kit and
cDNA was prepared using the Applied Biosystems High-Capacity cDNA
Reverse Transcription Kit, according to the manufacturers’ instructions.
Real-time PCR was performed on all samples, using Fast SYBR Green
(Applied Biosystems), according to the manufacturer’s instructions, on
a CFX96 Real-Time PCR System (Bio-Rad). Primers for atl and yqil (which
is a housekeeping gene that codes for acetyl coenzyme A) were designed
using NCBIPrimer-BLAST to be 20–24 bases long, have a GC content of
.50% and a melting temperature of 608C, and to amplify PCR products
of 137 and 243 bp for yqi and atl, respectively (Table 1). All reactions were
carried out in triplicate and expression of Atl was analysed by reference
to the expression of the housekeeping gene.
Statistical analysis
Descriptive statistics and ANOVA significance tests were performed with
Minitab version 15.
Results
Time–kill studies
The growth curves of EMRSA-15 NCTC 13142 in NB, NB containing
10% (w/v) AH and NB containing 2.5% (w/v) MH were similar
(Figure 1), with generation times of 30 min. Cultures of MRSA
incubated in NB containing 5%, 10% and 20% (w/v) MH, and in
NB containing 10% (w/v) AH and MGO showed loss of viability
(Figure 1). The extent of inhibition with AH containing MGO was
less than that with 5%, 10% or 20% (w/v) MH.
TEM
For each of the seven cultivation conditions tested here, the per-
centage of cells possessing evidence of partial and complete
septa was determined and plotted against time (Figure 2). On
average, 41% of untreated MRSA cells were found to contain
septal components over the observation period. Similarly, cells
treated with 2.5% (w/v) MH, 10% (w/v) AH and 10% (w/v) AH
containing MGO were found to exhibit septal components in
41%, 36% and 43% of cells, respectively, which was not statisti-
cally significantly different from untreated cultures (P.0.05
using one-way ANOVA). However, MRSA cultures exposed to
inhibitory concentrations of MH [5%, 10% and 20% (w/v)]
revealed a significantly higher proportion of cells containing
partial and complete septa compared with untreated cells
(64%, 71% and 67%, respectively; P,0.001 using one-way
ANOVA). These increases were established by 30 min and per-
sisted over 24 h. The effect did not appear to be dependent on
honey concentration between 5% and 20% (w/v) MH.
As a large number of electron micrographs were collected
during this study, only images of samples collected at 120 min
are presented to illustrate the structural changes observed in
MRSA (Figure 3). It was evident that uninhibited MRSA (Figure 3a,
b and c) appeared to be smaller than MRSA exposed to inhibitory
concentrations of MH (Figure 3d, e and f). Diameters of .500
cells for every timepoint for each culture condition were measured
and the means calculated. Data after 4 h of incubation are pre-
sented here (Table 2). Using two-way ANOVA, it was determined
that MRSA cells treated with 5%, 10% or 20% (w/v) MH from
30 min onwards had significantly larger cell diameters than cells
in untreated or uninhibited cultures [2.5% (w/v) MH] (P,0.001).
Table 1. Primers used in this study
Target gene Direction Sequence (5′ –3′)
Yqil forward GACGTGCCAGCCTATGATTT
Yqil reverse ATTCGTGCTGGATTTTGTCC
Atl forward AATCAAGGTGGCACACAACA
Atl reverse CTCGATGCTCATGATTGACG
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Figure 1. Time–kill curves of EMRSA-15 NCTC 13142.
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MRSA treated with AH or AH containing MGO or 2.5% (w/v) MH were
not significantly different in size from untreated cells at any
timepoint.
Determination of murein hydrolase activity
Murein hydrolase activity was estimated in the intracellular and
extracellular extracts prepared from MRSA cultivated in NB with
and without 10% (w/v) MH and in NB containing 10% AH at
seven different timepoints. Using the cell wall hydrolysis assay,
the activity of murein hydrolase was at undetectable levels in
all of the extracellular extracts prepared during this study and
marked differences in the activity of murein hydrolases were
detected only in intracellular extracts prepared at 24 h
(Figure 4). Compared with untreated MRSA, MRSA exposed to
AH exhibited increased levels of enzyme activity (by enhanced
hydrolysis of turbid cell wall suspension), but murein hydrolase
activity was not detected in MRSA exposed to MH (Figure 4).
These observations were confirmed by zymography (Figure 5),
where digestion of the cell walls was markedly reduced in intra-
cellular extracts of 24 h MH-treated cells compared with
untreated and AH-treated cells, but cell wall hydrolytic activity
was not at detectable levels in extracellular extracts.
Real-time PCR
Compared with untreated MRSA, the exposure of MRSA to 10%
(w/v) MH and 10% (w/v) AH containing MGO resulted in increased
levels of expression of atl by a factor of 5.5 and 5, respectively.
Discussion
Time–kill studies
Although the rate of inhibition of MRSA caused by MH was rela-
tively slow, with ,3 log reductions achieved in 24 h (Figure 1),
the time–kill curves presented here demonstrated a loss of via-
bility by MH at concentrations ≥5% (w/v) and concurred with
susceptibilities reported for staphylococci.11,12 These data indi-
cate that MH would have to be diluted by a factor of ≥20 to
reach subinhibitory levels. There is a need to know whether
honey would reach subinhibitory concentrations under the cir-
cumstances that may arise during clinical use. Undiluted
medical-grade honey destined for the topical treatment of
wounds is usually packaged into tubes or impregnated onto
wound dressing materials and sterilized by g irradiation. When
applied to wound surfaces, the sugars contained in honey nor-
mally promote the release of wound exudate, which inevitably
leads to dilution in vivo. It is unlikely that MH would be diluted
20 times in practice.
Undoubtedly, the sugars in undiluted honey contribute to its
antibacterial activity,1 but it was evident that 10% (w/v) AH did
not inhibit MRSA whereas 10% (w/v) MH did (Figure 1). An infer-
ence that the four major constituent sugars present in honey
were not entirely responsible for the inhibition of MRSA on
dilution was justified. MGO was added to AH and its efficacy
was compared with that of MH. The extent of inhibition of
MRSA exposed to 10% (w/v) AH containing MGO was less than
that of MRSA exposed to 10% (w/v) MH (Figure 1). Although
MGO has been claimed to be the prime active antibacterial com-
ponent of MH,4,5 our data suggest that it does not entirely
account for the inhibitory activity against MRSA. A recent study
in which the MGO contained in honey was neutralized showed
that residual inhibitory activity was detected against Escherichia
coli, Pseudomonas aeruginosa and Bacillus subtilis, but not
against S. aureus.27 Additionally, a laboratory study with MH
and honey infused with MGO indicated that MGO was only par-
tially responsible for antibiofilm activity against S. aureus.28
Hence, the antibacterial components of MH appear not to have
been completely characterized at present.
Structural studies
The benefit of using electron microscopy to elucidate the cytologi-
cal effects of antimicrobial agents on S. aureus as a means to
identify possible intracellular targets has been illustrated in
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Figure 2. Effect of honey with time on the percentage of MRSA cells containing septal components. The percentage of cells containing septal
components was determined from transmission electron micrographs of EMRSA-15 NCTC 13142 at ×20000 magnification. At least 12 images
were used for each sample collected.
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previous studies.29 – 32 Importantly, the accumulation of cells con-
taining whole or incomplete septa has shown that MH interrupted
the cell cycle of S. aureus.12 In this study, MRSA was incubated with
a range of honey concentrations for 24 h, rather than 10% (w/v)
MH for 4 h.12 Despite the gradual loss of viability of MRSA
exposed to inhibitory concentrations of MH (Figure 1), increased
numbers of cells containing septal components were evident
within 30 min (Figure 2), suggesting that effects on the cell cycle
were rapid. The inability of MRSA to complete cell division will
necessarily limit its ability to establish wound infection and is of
clinical significance.
The accumulation of cells with significantly larger diameters
following incubation with inhibitory concentrations of MH
(Figure 3 and Table 2) indicates that cells had reached a late
stage in the cell cycle, where cell division rather than metabolic
(a)
(b)
(c)
(g)
(d)
(e)
(f)
Figure 3. Effect of honey on the structure of MRSA cells. Transmission
electron micrographs show MRSA at ×32000 magnification following
incubation for 120 min in (a) NB, (b) NB containing 10% (w/v) AH, (c)
NB containing 2.5% (w/v) MH, (d) NB containing 5% (w/v) MH, (e) NB
containing 10% (w/v) MH, (f) NB containing 20% (w/v) MH, and (g) NB
containing 10% (w/v) AH with 614 mg/kg MGO. The percentage of cells
with septa was significantly increased following treatment with
concentrations of MH .2.5% (w/v) (P,0.001) and cells were also
significantly larger than control cells (P,0.001).
Table 2. Effect of honey on cell size in MRSA
Treatment conditions Cell diameter (mm) P
NB (untreated cells) 0.68+0.08 —
NB+2.5% (w/v) MH 0.67+0.07 .0.05
NB+10% (w/v) AH 0.62+0.09 .0.05
NB+10% (w/v) AH+MGO 0.65+0.08 .0.05
NB+5% (w/v) MH 0.81+0.09 ,0.001
NB+10% (w/v) MH 0.88+0.04 ,0.001
NB+20% (w/v) MH 0.80+0.08 ,0.001
Cell diameters (mm) of S. aureus were estimated after 4 h of incubation.
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Figure 4. Effect of MH on murein hydrolase activity. EMRSA-15 NCTC
13142 was cultivated in NB for 24 h with and without 10% (w/v)
honey, and extracellular extracts (EE) and intracellular extracts (IE)
prepared. The activity of murein hydrolase was assayed in triplicate
and the mean relative activity is presented as the percentage
turbidity+standard deviation.
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activity associated with increased cell volume was impaired. The
absence of lysed cells and cellular debris in electron micrographs
of MRSA exposed to ≥5% (w/v) MH suggests that the target site
of MH is not associated with cellular events that lead to autolysis.
MGO did not induce an increased formation of septal com-
ponents (Figure 2) or cell enlargement (Figure 3), which further
indicates the presence of unidentified inhibitory components in
MH. A search for additional antibacterial agents in MH might
be influenced by the observation of cell cycle perturbations in
MRSA that were induced by a component of green tea.32 So,
characterizing the polyphenols present in MH and evaluating
their effects on cell division in staphylococci may be a profitable
line of future enquiry.
Murein hydrolase activity
Inhibition of atl-negative mutants by MH suggested that murein
hydrolases were implicated in the failure of S. aureus to divide.12
The loss of activity of intracellular murein hydrolase in MRSA
incubated with NB containing 10% (w/v) MH for 24 h was
demonstrated in cell wall hydrolysis assays (Figure 4) and by
zymography (Figure 5). Conversely, real-time PCR demonstrated
that MH enhanced the expression of atl after 4 h compared
with untreated MRSA. This apparent contradiction may be
explained if MH affected the functionality of murein hydrolase
by interfering with the post-translational modification of the
enzyme. A similar deduction was reported in a strain of
S. aureus exhibiting intermediate resistance to vancomycin,
where zymographic analysis and microarray had revealed an
increased expression of autolytic enzymes, even though a
decreased autolysis was manifest in the phenotype.33
This study provides an insight into the effects of MH in the
inhibition of MRSA. The data demonstrate that the events of
the cell cycle are affected and that cell separation is interrupted,
although the precise mechanism is not explained. These effects
cannot be solely attributed to either the main constituent sugars
of honey or MGO, an important bioactive component. It is feas-
ible that MGO acts synergistically with other components in
honey. Honey has a complex chemistry and it is probable that
a multitude of effects will be induced by more than one of its
constituent components. Investigation of the inhibition of
E. coli by MH using transcriptome analysis demonstrated that it
induced multiple effects, with 2% of genes being up-regulated
and 1% down-regulated.34 Further investigation of gene
expression may help to elucidate the effects of MH on MRSA,
which are not yet explained.
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